BIOMAT Database Logo BIOMAT Database Logo

[Molecular analysis of erythroenzymopathies--phosphoglycerate kinase deficiency]. 1986

K Tani, and H Fujii

UI MeSH Term Description Entries
D010735 Phosphoglycerate Kinase An enzyme catalyzing the transfer of a phosphate group from 3-phospho-D-glycerate in the presence of ATP to yield 3-phospho-D-glyceroyl phosphate and ADP. EC 2.7.2.3. Kinase, Phosphoglycerate
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic

Related Publications

K Tani, and H Fujii
Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency.
January 1995, Muscle & nerve. Supplement,
K Tani, and H Fujii
[Phosphoglycerate kinase deficiency].
January 1998, Ryoikibetsu shokogun shirizu,
K Tani, and H Fujii
[Phosphoglycerate kinase deficiency].
January 2001, Ryoikibetsu shokogun shirizu,
K Tani, and H Fujii
Phosphoglycerate kinase deficiency.
July 1994, Neurology,
K Tani, and H Fujii
[Acquired erythroenzymopathies. II. Adenylate kinase deficiency in hemopathies].
October 1972, Pathologie-biologie,
K Tani, and H Fujii
[Congenital phosphoglycerate kinase deficiency].
August 1973, Nihon rinsho. Japanese journal of clinical medicine,
K Tani, and H Fujii
Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency.
January 2012, PloS one,
K Tani, and H Fujii
Immunochemical studies on phosphoglycerate kinase deficiency.
December 1986, Biochemical medicine and metabolic biology,
K Tani, and H Fujii
1,3-Diphosphoglycerate in phosphoglycerate kinase deficiency.
December 1973, Clinica chimica acta; international journal of clinical chemistry,
K Tani, and H Fujii
[Phosphoglycerate kinase deficiency with recurrent myoglobinuria: morphological and biochemical analysis].
January 1986, No to hattatsu = Brain and development,
Copied contents to your clipboard!